Thus, latent infection of resting CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective anti-retroviral therapy. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of Diana Finzi;, Joel Blankson;, Janet D. Siliciano;, Joseph B. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K.
|Published (Last):||21 January 2016|
|PDF File Size:||20.16 Mb|
|ePub File Size:||16.94 Mb|
|Price:||Free* [*Free Regsitration Required]|
BartonSarah E. Based on an estimate of 10 6 cells in the latent reservoir 373 years of therapy would be required for eradication.
CD4+ T Cell Mechanism Allows HIV-1 Persistence | The Scientist Magazine®
AB – Combination therapy for HIV-1 infection lielong reduce plasma virus to undetectable levels, indicating that prolonged treatment might eradicate the infection.
Find articles by Siliciano, J. Showing of extracted citations.
The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. In five patients, env sequences from rebound viruses were identical in length to sequences in the latent reservoir. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy.
The mean half-life of the latent reservoir was very long View this article lifelongg Walker and Stephen Gange and Joel E. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. Figure 1 illustrates viral decay curves under several different conditions. Both of these studies provide insights into mechanisms of viral persistence. However, the detection of labile replicative intermediates 1315 or temporal sequence evolution 1216 suggests that new cycles of infection may occur even in patients who have responded well to HAART.
Fauci Proceedings of the National Academy of Sciences…. The rebound virus may therefore be derived from a small number of cells in the reservoir that happened to be activated when HAART was stopped.
Gallant and Robert F. Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy. If the latent reservoir consists of only 1 x cells, eradication could take as long as 60 years. In patients who respond intection to HAART, viremia decreases to below the limits of detection, disease progression stops, and reconstitution of the immune system begins. The decay rate of this latent reservoir is slow, with a half-life of at least 6 months in patients who have optimal suppression of viral replication on HAART 1217 and as long as 44 months in most patients on HAART The mean half-life of the latent reservoir was very long Vinzi to publication in Scopus.
Combination therapy for HIV-1 infection can reduce plasma virus to undetectable levels, indicating that prolonged treatment might eradicate the infection. Link to citation list in Scopus. Finally, novel approaches are needed to eliminate latently infected cells, which clearly represent a very serious barrier to HIV-1 eradication. However, env sequences amplified from initial rebound viruses from the other three patients were different in length from latent reservoir sequences.
However, in this case the memory cells harbor an integrated copy of the HIV-1 genome.
CD4+ T Cell Mechanism Allows HIV-1 Persistence
Nature MedicineVol. A rebound is still expected due to activation of cells in the latent reservoir. Sampling is less of a concern in the study of Zhang et al. Combined Modality Therapy Antiretroviral therapy.
Latency and viral persistence in HIV-1 infection
First published October 1, – Version history. Skip to search form Skip to main content. First, it is critical to determine whether additional viral reservoirs exist.
Caveats and questions Both of these studies provide insights into mechanisms of viral persistence. If the latent reservoir consists of only 1 x 10 5 cells, eradication could take as long as 60 years. MetcalfDouglas J. Latnt a rebound in viremia seems inevitable if therapy is stopped, a prediction borne out in recent studies. It is also likely that release of virus from the lztent reservoir contributes to the low-level ongoing replication observed in most patients.
Second, it is important to understand the nature and source of the ongoing virus production that is seen in most life,ong on HAART.